Bluefin Capital Management’s Cytosorbents CTSO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
– Sell
-688
Closed -$77K – 521
2015
Q4
$77K Buy
+688
New +$93.7K 0.01% 480

Other funds holding CTSO

Bluefin Capital Management's CTSO Position: Q1 2016 in Review

Bluefin Capital Management sold out of Cytosorbents (CTSO) in Q1 2016, closing a stake of 688 shares — an estimated $77K sold.

Bluefin Capital Management first reported a position in CTSO in Q4 2015 and held it in 1 quarter. The position peaked at $77K in Q4 2015. 33 funds tracked by Wall St. Rank hold CTSO as of Q1 2016.

  • Bluefin Capital Management reported no remaining Cytosorbents position as of Q1 2016 after selling out during the quarter.
  • Bluefin Capital Management sold 688 Cytosorbents shares in Q1 2016, an estimated $77K.
  • Bluefin Capital Management first reported a position in Cytosorbents in Q4 2015 and held it in 1 quarter.
  • Bluefin Capital Management's Cytosorbents position peaked at $77K in Q4 2015.
  • 33 funds tracked by Wall St. Rank held Cytosorbents as of Q1 2016.

Based on Bluefin Capital Management's 13F filing for Q1 2016, filed 16 May 2016.